Unity biotechnology inc.

Major-Pharmaceuticals

UBX


3280 Bayshore Boulevard
Brisbane , CA 94005

Executive/
Director

Price

  • Last Close
  • $ 1.26
    $ +0.14 12.5 %
    Jan 3, 2025
  • 52-Week High/Low
  • $2.65 - $1.26
  • YTD
  • 29.1%

  • Trading Volume
  • 7,983
  • Market Cap Full
  • $ 18.4M
  • Shares Outstanding
  • 14.6M
    Nov 8, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - -50.1% -5% 12.4% -21.5% -40.5% -14.5% 29.1%
Q2 - - -9.6% 8.1% 4% -21.8% -51% 56.4% -18.6% -
Q3 - - 9.8% -34.5% 8% -35.3% 600.4% -5.9% 10% -
Q4 - - 1.7% 16.8% 52.5% -51.2% -30.6% -7.2% -18.7% -
J F M A M J J A S O N D
2025 29.1% - - - - - - - - - - -
2024 -10.4% 5.8% -9.8% -9.1% 4.5% -13.3% 10.3% 10% - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%-55%-29%-72%87%-30%-49%29%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - -4.69 -0.44 -0.59 -0.29 -2.8 -0.76
Q2 - - -0.76 -0.56 -0.38 -0.32 -1.9 -0.85
Q3 - - -0.45 -0.51 -0.52 -0.3 -1.36 -1.05
Q4 - - -0.53 -0.39 -0.37 -1.81 -0.25 -
A 0 0 -6.4 -1.9 -18.5 -10.9 -6.3 -2.66

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 42.9 47.6 54.7 68.9 14.3
Jun 42.3 42.9 49.1 54.9 69.2 14.4
Sep 42.3 43.2 52 55.1 69.7 14.6
Dec 42.3 45.9 52.9 57.7 14.2 14.6

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - 0.4 - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio 0.1 0.2 0.3 - -
Debt – Equity Ratio 0.2 0.3 0.3 - -
Interest Coverage -29 -14.3 - 11.3 26.3
Equity multiplier 0.1 0.2 0.4 0.2 0.1